Joint FDA-FTC Statement Regarding Collaboration to Advance Competition in the Biologic Marketplace
Date
Matter Number
V190003
Displaying 341 - 360 of 1549
Statement of the FTC Chairman Regarding Announcement that Aveanna Healthcare and Maxim Healthcare Services have Terminated Their Acquisition Agreement
Date
The Â鶹´«Ã½ Trade Commission has closed its investigation into the proposed merger of Aveanna Healthcare and Maxim Healthcare. “Staff of the Bureau of Competition and Bureau of Economics have...
FTC and NY Attorney General Charge Vyera Pharmaceuticals, Martin Shkreli, and Other Defendants with Anticompetitive Scheme to Protect a List-Price Increase of More Than 4,000 Percent for Life-Saving Drug Daraprim
Date
The Â鶹´«Ã½ Trade Commission has filed a complaint in federal court against Vyera Pharmaceuticals, LLC, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug...
Illumina Inc./Pacific Biosciences of California, Inc., In the Matter of
The Â鶹´«Ã½ Trade Commission authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California, alleging in an administrative complaint that Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for next-generation DNA sequencing systems by extinguishing PacBio as a nascent competitive threat. The Commission vote to issue the administrative complaint and to authorize staff to seek a temporary restraining order and preliminary injunction was 5-0. On Jan. 2, 2020, the parties abandoned the transaction.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
1910035
Docket Number
9387
Case Status
Closed
FTC Comments to State Legislatures in Kansas and Ohio Encourage Granting Advanced Practice Registered Nurses Full Practice Authority
Date
Â鶹´«Ã½ Trade Commission staff submitted comments to two state legislatures on the impact of legislative proposals to modify the supervision requirements imposed on advanced practice registered nurses...
FTC Staff Comment to the Kansas House of Representatives Concerning Kansas House Bill 2412
Date
Matter Number
V200006
FTC staff comment concerning Kansas House Bill 2412, a proposal to expand the scope of practice for Advanced Practice Registered Nurses (APRNs) in Kansas.
File
Text of the Staff Comment
(1.3 MB)
FTC Staff Comment to the Ohio House of Representatives Concerning Ohio House Bill 177
Date
Matter Number
V200005
Comment by FTC staff concerning Ohio House Bill 177, a proposal to expand the scope of practice of Advanced Practice Registered Nurses (APRNs) in Ohio.
File
Text of FTC Staff Comment
(20.44 MB)
Statement of Gail Levine, Deputy Director of FTC Bureau of Competition, Regarding the Announcement that Illumina Inc. has Abandoned Its Proposed Acquisition of Pacific Biosciences of California
Date
Following today’s announcement that the parties are abandoning their proposed merger, Gail Levine, Deputy Director of the Bureau of Competition, made this statement: “This deal threatened to let a...
FTC Challenges Illumina’s Proposed Acquisition of PacBio
Date
The Â鶹´«Ã½ Trade Commission has authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California (PacBio). The Commission alleges in an...
Statement of the Â鶹´«Ã½ Trade Commission in the matter of Roche Holding/Spark Therapeutics
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Rohit Chopra, Former Commissioner;
Rebecca Kelly Slaughter, Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
191 0086
Â鶹´«Ã½ Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.
Date
The Â鶹´«Ã½ Trade Commission has closed its investigation into Roche Holding AG’s proposed acquisition of Spark Therapeutics, Inc. According to a Commission Statement, after an exhaustive, 10-month...
FTC Comment to Texas Medical Board Raises Competitive Concerns about Proposed Rule Imposing Additional Supervisory Requirements on Texas-Certified Nurse Anesthetists
Date
The Â鶹´«Ã½ Trade Commission staff has submitted a comment to the Texas Medical Board raising concerns that the board’s Proposed Rule § 193.13 could harm competition by impeding access to surgical and...
FTC Submits Comment in Favor of Amendments to North Carolina’s Administrative Code that would Promote Expanded Access to Preventive Dental Services
Date
The Â鶹´«Ã½ Trade Commission staff has submitted a comment to the North Carolina State Board of Dental Examiners expressing support for proposed changes to the North Carolina Administrative Code that...
FTC Staff Comment to the North Carolina State Board of Dental Examiners Regarding Proposed Rule Changes to 21 N.C. Admin. Code 16W
Date
Matter Number
V200003
File
Text of the Staff Comment
(178.29 KB)
Statement of Commissioner Noah Joshua Phillips In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Noah Joshua Phillips, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Rebecca Kelly Slaughter, Commissioner
Matter Number
191 0061
Docket Number
C-4690
Displaying 341 - 360 of 1549